vimarsana.com

Page 2 - Research In Multiple Sclerosis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds

Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.

United statesDalia rotsteinUniversity of torontoResearch in multiple sclerosisAmericas committee for treatmentAmericas committeeMultiple sclerosisSclerosis concept mapAmerican journalWhite europeanNorthern europeans

GLP-1 Therapy Well Tolerated Among Patients With Multiple Sclerosis

GLP-1 therapy was well tolerated among patients with multiple sclerosis and obesity, with an average weight loss of 12 lb.

United statesWest palm beachAmericas committee for treatmentResearch in multiple sclerosisAmericas committeeMultiple sclerosisMassachusetts general

GLP-1 Therapy Well Tolerated Among Patients With Multiple Sclerosis

GLP-1 therapy was well tolerated among patients with multiple sclerosis and obesity, with an average weight loss of 12 lb.

United statesWest palm beachAmericas committee for treatmentResearch in multiple sclerosisAmericas committeeMultiple sclerosisMassachusetts general

Immunic (IMUX) Presents Data From Phase 2 CALLIPER and CALVID-1 Trials of Vidofludimus Calcium

Immunic (IMUX) Presents Data From Phase 2 CALLIPER and CALVID-1 Trials of Vidofludimus Calcium
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDaniel vittRobertj foxAlexandra herrmannResearch in multiple sclerosisNeurological instituteMellen centerImmunic incAmericas committee for treatmentAmericas committeeMultiple sclerosisPalm beachChief executive officerVidofludimus calciumSerum neurofilamentStaff neurologist

Immunic Presents Data From Phase 2 CALLIPER and CALVID-1 Trials of Vidofludimus Calcium at the ACTRIMS Forum 2024

Immunic Presents Data From Phase 2 CALLIPER and CALVID-1 Trials of Vidofludimus Calcium at the ACTRIMS Forum 2024
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesEdna kaplanPaula schwartzJessica breuDaniel vittRobertj foxAlexandra herrmannMellen centerExchange commissionNeurological instituteResearch in multiple sclerosisAmericas committee for treatmentImmunic incAmericas committeeMultiple sclerosisPalm beach

vimarsana © 2020. All Rights Reserved.